Matthew L Sherman Deciphera Pharmaceuticals, Inc. (DCPH) insider trading activity

DCPH Quotes by TradingView

Matthew L Sherman is EVP & Chief Medical Officer of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Oct 02, 2020, when has been sold 2,632 shares (Common Stock) at a price of $51.15 per share, resulting in proceeds of $134,627. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Matthew L Sherman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2020
SELL
Payment of exercise price or tax liability
$134,627 $51.15 p/Share
2,632 Reduced 7.16%
34,128 Common Stock

Also insider at

PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
Director
MLS

Matthew L Sherman

EVP & Chief Medical Officer
Waltham, MA

Track Institutional and Insider Activities on DCPH

Follow Deciphera Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DCPH